AZD0780;EX-A6975;laroprovstatum; laroprovstat

Non Chimik:

6'-(((1S,3S)-3-((5-(difluoromethoxy)pyrimidin-2-yl)amino)cyclopentil)amino)-2H-[1,3'-bipiridin]-2-yon

Kòd SMILES:

O=C1N(C=CC=C1)C2=CN=C(N[C@@H]3C[C@H](CC3)NC4=NC=C(OC(F)F)C=N4)C= C2

Kòd InChi:

InChI=1S/C20H20F2N6O2/c21-19(22)30-16-11-24-20(25-12-16)27-14-5-4-13(9-14)26-17-7-6- 15(10-23-17)28-8-2-1-3-18(28)29/h1-3,6-8,10-14,19H,4-5,9H2,(H,23,26 )(H,24,25,27)/t13-,14-/m0/s1

InChi kle:

NCHUWRLOTSAFFN-KBPBESRZSA-N

Mot:

2455427-91-3；CAS:2455427-91-3；CAS:2455427-91-3；AZD0780; AZD0780; AZD0780; EX-A6975; EX-A 6975; EXA6975; laroprovstatum; laroprovstat

Solibilite: 

Depo:Sèk, nwa ak nan 0 -4 C pou kout tèm (jou a semèn) oswa -20 C pou tèm long (mwa a ane).

Deskripsyon:

PCSK9-IN-12 se yon konpoze heteroaromatic. PCSK9-IN-12 gen afinite obligatwa pou PCSK9 ak yon valè Kd<200 nM. PCSK9-IN-12 ka itilize pou etid metabolis kolestewòl.

Sib: PCSK9